Evidence-Based Oncology > April 2018

Evidence-Based Oncology - April 2018

April 16, 2018 – Peter Aran, MD
Risk has very different meanings depending on whether one views it from a clinical or financial perspective.
April 16, 2018 – Susan Dentzer
It is important to establish broadly agreed-on and accepted frameworks for thinking about the value of high-cost cancer therapies, so that we as a society can weigh the choices in front of us.
April 16, 2018 – Lani M. Alison, BSN, MS-HCQ, PCMH CCE
Oncology nurse navigators provide the “constant” in what seem to be undulating waves of changes to workflows, the adoption of new technology, the near-weekly onslaught of new drugs, and the need to ensure every nuance of documentation is entered in discrete fields in electronic health records so the practice meets reporting requirements.
April 16, 2018 – Kashyap Patel, MD; Maharshi Patel, MBA; Asutosh Gor, MD; Sashi Naidu, MD; Niyati Nathwani, MD; Radhee Kothadia, BS; Saheli Parekh; and Eric Singhi, MD
One possible way to reduce overall cost, improve patient experience, and improve outcomes in cancer care is to shift the focus of healthcare delivery away from volume and toward value. Patient-centered cancer care holds the promise of addressing these issues.
April 17, 2018
Coverage from the American Society of Clinical Oncology Genitourinary Cancers Symposium, held February 8-10, 2018, in San Francisco, California
April 18, 2018
Coverage from the Association of Community Cancer Centers’ 44th Annual Meeting & Cancer Center Business Summit, March 14-16, 2018, in Washington, DC.
April 23, 2018
ASCO reviews clinical pathways; Flatiron Health acquired
April 24, 2018 – Joseph Alvarnas, MD
Dr Alvarnas is editor-in-chief and director of Value-Based Analytics at City of Hope, Duarte, California.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.